Alkermes (ALKS) FCF Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 253.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1,444.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,941.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4,671.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1,067.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -42,016.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 830.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 895.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 22,587.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,016.00 |
| Dec 31, 2025 | 4,718.00 |
| Sep 30, 2025 | 32,918.00 |
| Jun 30, 2025 | 41,849.00 |
| Mar 31, 2025 | 2,395.00 |
| Dec 31, 2024 | 3,512.00 |
| Sep 30, 2024 | -711.00 |
| Jun 30, 2024 | 2,608.00 |
| Mar 31, 2024 | 2,478.00 |
| Dec 31, 2023 | 179.00 |
| Sep 30, 2023 | 208.00 |
| Jun 30, 2023 | 3,943.00 |
| Mar 31, 2023 | 1,461.00 |
| Dec 31, 2022 | -20,495.00 |
| Sep 30, 2022 | -31,230.00 |
| Jun 30, 2022 | -36,941.00 |
| Mar 31, 2022 | 563.00 |
| Dec 31, 2021 | -8,198.00 |
| Sep 30, 2021 | 1,965.00 |
| Jun 30, 2021 | -100,401.00 |